NCT03185806: EPCDSAP

A Trial of Early Percutaneous Catheter Drainage of Sterile Pancreatic Fluid Collections in Severe Acute Pancreatitis

Status unknown NA Last updated 9 October 2017

What this trial tests

NA trial testing Puncture and drainage in Severe Acute Pancreatitis in 100 participants. Status unknown.

Timeline

6 October 2017

Primary endpoint
6 October 2020

6 October 2020

Quick facts

Lead sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	6 October 2017
Primary completion	6 October 2020
Estimated completion	6 October 2020
Sites	1 location across China

Drugs / interventions tested

• Puncture and drainage

Conditions studied

• Severe Acute Pancreatitis — all drugs for Severe Acute Pancreatitis →

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

Adults 18 to 70, any sex, with Severe Acute Pancreatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The acute peripancreatic fluid collections (AFPCs) is the most common complication in severe acute pancreatitis (SAP). There are controversies on optimal timing for drainage of APFCs in SAP. The early-stage percutaneous catheter drainage (PCD) of sterile peripancreatic fluid collections is questioned as a result of the major cause of secondary infection. The aim of the present randomized controlled trial is to compare the outcomes in terms of mortality, secondary infection of peripancreatic collections, organ failure, length of hospital/ICU stay and inflammatory biomarkers between the early-stage PCD of sterile AFPCs and conservative therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.